Showing results (31-40 of 89) with videos related to
Sort By:
Pageof 9
Frontiers in Oncology|November 25, 2022
Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case reportFrancesco Schettini, Elia Seguí, Benedetta Conte, et al.Blood|November 6, 2008
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profilingSílvia Beà, Itziar Salaverria, Lluís Armengol, et al.Virchows Archiv : an International Journal of Pathology|February 6, 2022
Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter studySonia Gatius, Ana Velasco, Mar Varela, et al.Journal of Thoracic Disease|April 12, 2021
Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practiceJosé Manuel González de Aledo-Castillo, Ainara Arcocha, Iván Victoria, et al.Blood|November 19, 2020
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigeneticsFerran Nadeu, Romina Royo, Guillem Clot, et al.European Journal of Cancer (Oxford, England : 1990)|May 17, 2014
RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapyVirginia Alonso-Espinaco, Miriam Cuatrecasas, Vicente Alonso, et al.Breast (Edinburgh, Scotland)|April 8, 2025
Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative reviewJavier Muñoz, Sabrina Nucera, Nuria Rubira Garcia, et al.Cancer Research|December 17, 2008
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemiaAnna Enjuanes, Yolanda Benavente, Francesc Bosch, et al.Leukemia|December 12, 2022
Tumorigenic role of Musashi-2 in aggressive mantle cell lymphomaMarta Sureda-Gómez, Patricia Balsas, Marta-Leonor Rodríguez, et al.Cancer Research|August 20, 2009
MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomasAlba Navarro, Sílvia Beà, Verónica Fernández, et al.Pageof 9